PCL Alverno to Highlight Partnership with Beckman Coulter
News Oct 14, 2016
PCL Alverno (Hammond, Ind.), recipient of the prestigious ADVANCE Laboratory of the Year award for 2016, will share its strategies for implementing a culture of continuous improvement and lab efficiency at the 10th Anniversary Lab Quality Confab, held October 18-19, 2016, in New Orleans. The talk will feature the successful partnership between PCL Alverno and Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry.
Director of Quality Assurance at PCL Alverno, Don Lair, Jr., will lead the session, titled, “Our Journey to Implement the Culture of Continuous Improvement in 26 Hospital Labs and the Alverno Central Lab: What’s Worked Best for Us With Methods and Metrics.”
Lair will chronicle the challenges faced by one of the largest regional laboratory networks in the Midwest, as it sought to drive performance across multiple facilities with different needs and test volumes. Standardization of test instrumentation and IT infrastructure along with the development of unifying culture of continuous improvement have proven to be the key ingredients to Alverno’s success.
This transformation has been accomplished in partnership with Beckman Coulter, using the principles and tools of the Danaher Business System (DBS) model employed by Beckman Coulter, which Alverno adopted.
“DBS is a tremendous tool we adopted through our partnership with Beckman Coulter. With it, our team unleashed a unique set of skills that are driven by Lean strategies, but in fact, are so much more. We have been involved with Lean for more than a decade, with great success, but never at the level we’re seeing today, and never with results so quickly,” said Sam Terese, President and CEO of Alverno.
The DBS is a philosophy, set of values and series of management processes utilized by Danaher Corporation and Beckman Coulter. The success of the DBS philosophy has been heralded in a number of publications, including the Wall Street Journal, Business Week and the Harvard Business Review. DBS in the laboratory builds and sustains a culture of continuous improvement and employee engagement. The result is improved quality, speed to results, operational efficiency, physician satisfaction and, ultimately, patient care.
The attendees of Lab Quality Confab are invited to learn more about the application of DBS to laboratory operations at the Beckman Coulter booth.
Test For Designer Drugs Could Help Treat Overdose PatientsNews
Medical professionals are scrambling to meet the growing demand for emergency room treatment, but they’re hampered by the lack of a quick and easy test to screen patients for “designer” drugs. Chemists have now developed such a test and are refining it with the hope that hospitals could eventually use it to choose the appropriate treatment.READ MORE
Cancer ‘Signature’ First Step Toward Blood Test for PatientsNews
A discovery by Melbourne researchers could help to identify patients with a particularly aggressive type of lung cancer that are likely to respond to immunotherapies currently used in the clinic to treat other cancers.READ MORE
Comments | 0 ADD COMMENT
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018
World Congress on Plant Science and Molecular Biology
Sep 12 - Sep 13, 2018